Astaxanthin attenuated thrombotic risk factors in type 2 diabetic patients
The anti-coagulatory effects of astaxanthin (AX) in type 2 diabetic patients were demonstrated. Diabetic patients were randomly assigned into three groups: placebo, low AX (L-AX, 6 mg AX/day) and high AX (H-AX, 12 mg AX/day). The plasma levels of coagulation factors including plasminogen activator i...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-02-01
|
| Series: | Journal of Functional Foods |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1756464618306418 |